Lipocine Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 53630X203 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Squadron Capital Management LLC 13G/A Amendment 3	9.8%	810,000	13G/A Amendment 3	8/14/2026 Event 6/30/2026
Squadron Master Fund LP	9.8%	810,000
Squadron Capital Management LLC	9.8%	810,000
Matthew Sesterhenn	9.8%	810,000
William Blank	9.8%	810,000
Squadron Capital Management LLC 13G/A Amendment 2	6.2%	450,000	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Squadron Master Fund LP	6.2%	450,000
Squadron Capital Management LLC	6.2%	450,000
Matthew Sesterhenn	6.2%	450,000
William Blank	6.2%	450,000
Squadron Capital Management LLC 13G/A Amendment 1	9.5%	530,000	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Squadron Master Fund LP	9.5%	530,000
Squadron Capital Management LLC	9.5%	530,000
Matthew Sesterhenn	9.5%	530,000
William Blank	9.5%	530,000
Squadron Capital Management LLC 13G	9.0%	500,000	13G	12/23/2025 Event 12/18/2025
Squadron Master Fund LP	8.0%	444,632
Squadron Capital Management LLC	9.0%	500,000
Matthew Sesterhenn	9.0%	500,000
William Blank	9.0%	500,000

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	36	2.98 M	$7.63 M	$0
2026 Q1	48	3.28 M	$26.2 M	$0
2025 Q4	26	1.63 M	$13.1 M	$0
2025 Q3	22	529 k	$1.51 M	$0
2025 Q2	19	528 k	$1.67 M	$0
2025 Q1	20	517 k	$1.65 M	$0
2024 Q4	18	487 k	$2.38 M	$0
2024 Q3	20	545 k	$2.45 M	$0
2024 Q2	21	534 k	$4.40 M	$0
2024 Q1	22	475 k	$2.47 M	$0
2023 Q4	23	485 k	$1.35 M	$240 k
2023 Q3	23	500 k	$1.48 M	$256 k
2023 Q2	26	478 k	$2.40 M	$436 k
2021 Q3	1	1.00 k	$1.09 k	$0
2021 Q2	1	1.00 k	$1.40 k	$0
2021 Q1	1	1.00 k	$1.51 k	$0